Navigation Links
Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology
Date:1/10/2011

CAMBRIDGE, Mass. and NEW YORK, Jan. 10, 2011 /PRNewswire/ -- Resolvyx Pharmaceuticals (Resolvyx) and Celtic Therapeutics Holdings L.P. (Celtic Therapeutics), a successor firm to Celtic Pharma, announced today that they have entered into a final agreement under which Celtic Therapeutics has acquired and licensed worldwide rights related to Resolvyx's RX-10045, a late-stage program for the treatment of dry eye syndrome and other ophthalmic conditions.  Terms of the deal include upfront consideration, near-term milestone payments, and funding for 100% of future development costs. Resolvyx and Celtic Therapeutics will share proceeds from the future divestiture of RX-10045, including up-front payments, royalties or other revenues.

Under the terms of the agreement, Celtic Therapeutics will acquire and license rights to Resolvyx's RX-10045, in all ophthalmic indications. RX-10045 is scheduled to enter a Phase III randomized, placebo-controlled, multi-center study in 2011. As part of the agreement, Celtic Therapeutics may also license rights to and develop a second Resolvyx compound in a topical formulation for ophthalmic indications.

Resolvins are a recently discovered family of naturally-occurring, small molecule lipid mediators that can be targeted to treat a wide range of diseases. Resolvins are shown to be highly potent and efficacious across a broad range of pre-clinical models of asthma, atherosclerosis, rheumatoid arthritis, inflammatory bowel disease, dry eye and retinal disease, among others. Resolvyx will continue to develop Resolvins for non-ophthalmic indications.

Dry eye, one of the most common problems treated by ophthalmologists, and a $1.7 billion global market today, is a chronic, multifactorial disease involving inflammation of the tear ducts and ocular surfaces that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surfaces. RX-10045, a resolvin
'/>"/>

SOURCE Celtic Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Celtic Therapeutics and Resolvyx Pharmaceuticals Announce an Alliance in Ophthalmology
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... NEW YORK , April 24, 2015 /PRNewswire/ ... Diseases (NIAID) (part of the National Institutes of ... million to nine research projects for the development ... light of  recent HAI outbreaks at U.S. health ... are supporting research into rapid, multiplexed and effective ...
(Date:4/24/2015)... Spain , April 24, 2015  Elekta has ... Monaco® treatment planning system , enabling European clinics ... supports major treatment techniques including advanced 3D planning, IMRT, ... system. Monaco ... as well improved workflow efficiency. Advancements in 3D planning ...
(Date:4/23/2015)... , April 23, 2015 Once again, BeaconMedaes ... our commitment to patient safety. BeaconMedaes, priority ... against infectious disease. The next generation Zone ... gas sensors are now mounted in the assembly, allowing ... to open ceiling tiles potentially releasing dust spores and ...
Breaking Medicine Technology:Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4Elekta CE marks for Monaco v5.10 treatment planning system 2BeaconMedaes launches new Zone Valve Box Assembly 2
... 2007 /PRNewswire/ -- Two studies presented,today demonstrated that ... levels, nor did it impair middle-of-the-night balance,mobility or ... The results of the studies were presented at ... Societies,(APSS). , "These data are important because they ...
... Sustained Improvement in Signs and,Symptoms Of Moderate to ... Disease Remission at One-Year,Mark , BARCELONA, Spain, ... percent of patients with moderate to severe rheumatoid ... and maintained at least 20 percent improvement in,arthritis ...
Cached Medicine Technology:Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 2Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 4Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 5Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 2Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 3Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 5
(Date:4/24/2015)... Multi Customer Discount , Rules: This ... http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 gallons in Zeiter's Septics service ... does not include any Dig fees, or any other ... If someone is part of this group event and ... 2500 gallons or more, the cost would be $300.00. ...
(Date:4/24/2015)... 24, 2015 Lipitor lawsuits ( ... the federal multidistrict litigation underway in U.S. District ... documents, the parties involved in the proceeding submitted ... among other things, preparation for the litigation’s upcoming ... both plaintiffs and defendants have conducted depositions of ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Carinsurancequotesinfo.com has ... blog post explaining how to qualify for auto ... parents can qualify for auto insurance online, without having ... post explains that single parents can reduce their auto ... released article and properly explained. , Clients can ...
(Date:4/24/2015)... Missouri (PRWEB) April 24, 2015 With ... veterinarians , UGA is now proud to be partnered ... care of 16,000 animals a year. This partnership has ... for their animals. , After providing an in-house ... Veterinary Medical Teaching Hospital (VMTH) wanted to increase financing ...
(Date:4/24/2015)... 24, 2015 MMJ Physician Practice ... patients looking to enroll in the Massachusetts medical ... a mile away from Alternative Therapies Group (ATG), ... open this summer. With the dispensary nearby, ... go-to place for residents of eastern Massachusetts to ...
Breaking Medicine News(10 mins):Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:Medical Doctor from Salem Massachusetts Supports the Medical Marijuana Industry 2
... study quantifies ROI of Lumension,s integrated application whitelisting and vulnerability ... ... Scottsdale, Ariz. (PRWEB) December 16, 2008 -- ... functions have on the enterprise, Lumension Security ™, Inc., ...
... features the latest news, facts and nutritional updates about acai berries. ... and the acai berry fruit to help the general public better ... ... Dallas, TX (PRWEB) December 16, 2008 -- The announcement of ...
... analysis of a large, multicenter clinical trial has shown ... and somewhat lower in fat compared to standard federal ... subgroup of early-stage breast cancer survivors women who ... These patients typically have higher recurrence and lower survival ...
... Dec. 15 Dechra Veterinary Products,LLC today announces ... market,VETORYL(R) Capsules. , ... has been demonstrated,to be effective in the treatment ... for use in pituitary-dependent hyperadrenocorticism, which,comprises the majority ...
... Nurses Call on County to Halt Questionable Contract , ... nation,s largest nurses union today charged that Jackson Health System (JHS) ... protects employee rights, and is calling on Miami-Dade County Commissioners to ... hospital system and SEIU. , , ...
... found the dynamic raised cardiovascular risks by 50% , , ... risk of heart attack and other cardiovascular problems by ... , "The study suggests that people with psychological stress ... disease event over the follow-up period," said Mark Hamer, ...
Cached Medicine News:Health News:Lumension Provides Leading e-Commerce Company Proactive Endpoint Security at a High Return 2Health News:Lumension Provides Leading e-Commerce Company Proactive Endpoint Security at a High Return 3Health News:Lumension Provides Leading e-Commerce Company Proactive Endpoint Security at a High Return 4Health News:AcaiBerryMD.com Explains the Real Facts About the Acai Berry Fruit 2Health News:AcaiBerryMD.com Explains the Real Facts About the Acai Berry Fruit 3Health News:Diet may cut second breast cancers in women without hot flashes 2Health News:Diet may cut second breast cancers in women without hot flashes 3Health News:RNs Charge Jackson Health System, Service Union Broke State Law in Harassment of Hospital Nurses 2Health News:RNs Charge Jackson Health System, Service Union Broke State Law in Harassment of Hospital Nurses 3Health News:Stress Triggers Heart-Damaging Behavior 2
... disposable lens convenience for those with astigmatism ... crisp, clear vision with the convenience of ... Toric lenses are manufactured using our patented ... perfect edge on every lens. This lens ...
The Heine C series binocular loupes offer extremely low weight (46 g), crisp views, and quality German construction in an affordable instrument....
Eyeglass Loupe 3x-5x made with precision optical glass. Ideal for any detail work....
Near PT test card/illus of the ocular adnexa 5 1/2" X 8"....
Medicine Products: